AACE Master Class Live

May 21, 2020   4:00 pm EDT

Kenneth Cusi, MD, FACE

Learning Objectives:

• Discuss the disease burden and the role of type 2 diabetes mellitus in the development of steatohepatitis and cirrhosis.
• Describe the diagnostic pathways for NAFLD.
• Review current treatment options and the upcoming drugs in the research pipeline.

Kenneth Cusi, MD, serves as Chief of the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine at the University of Florida. He received his medical degree in Argentina from the University of Buenos Aires School of Medicine and is board certified in both Internal Medicine and Endocrinology, Diabetes & Metabolism. He completed his residency at the Center of Medical Education & Clinical Research (CEMIC) in Buenos Aires, Argentina, and a clinical fellowship at Baylor College of Medicine in Houston.

Prior to joining the University of Florida, Dr. Cusi was a faculty member of over 15 years in the Diabetes Division at the University of Texas Health Science Center at San Antonio (UTHSCSA) and the Veterans Health Administration System in Texas - one of the leading diabetes programs in the country. He is a fellow of the American College of Physicians (ACP) and the American Association of Clinical Endocrinologists (AACE).

He has actively participated in many clinical diabetes programs and in the training of many young researchers and clinicians. He is the principal investigator of various ongoing clinical translational research projects in obesity, Type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD).